PCVX Form 144: Affiliate resale notice, 22,461 shares sold

PCVX Form 144 notice listing proposed resales of Common stock through UBS Financial Services and documenting recent affiliate sales.

Rhea-AI Filing Summary

PCVX Form 144 notice listing proposed resales of Common stock through UBS Financial Services and documenting recent affiliate sales.

The filing lists securities by grant type and vest date with quantities (for example: RSU Vest 03/02/2025 — 2,410 shares; Founder Shares 12/09/2013 — 2,000 shares; other RSU vests of 7,752 and 12,075). The filing also reports sales during the past three months: Grant Pickering sold 22,461 shares on 06/18/2026 for $1,179,204.75; The Claire Pickering 2020 Delaware Trust sold 1,000 shares for $52,500.00; and The Benjamin Pickering 2020 Delaware Trust sold 1,000 shares for $52,500.00, all on 06/18/2026.

Insights

Corporate Governance Specialist

Notice documents affiliate resales and recent insider transactions.

The filing records proposed resales of Common shares tied to named grants and vest dates and discloses three recent sales on 06/18/2026. The listing groups securities by grant type (e.g., RSU Vest, Founder Shares) with explicit per-grant quantities.

These are disclosure-level resale notices; the cash-flow treatment and any broker terms are not provided in the excerpt. Subsequent filings may show additional resale activity or distribution mechanics.

Key Figures

Grant Pickering sale: 22,461 shares Proceeds from Grant Pickering sale: $1,179,204.75 Claire Pickering Trust sale: 1,000 shares +5 more

8 metrics

Grant Pickering sale 22,461 shares sold on 06/18/2026

Proceeds from Grant Pickering sale $1,179,204.75 sale on 06/18/2026

Claire Pickering Trust sale 1,000 shares sold on 06/18/2026 for $52,500.00

Benjamin Pickering Trust sale 1,000 shares sold on 06/18/2026 for $52,500.00

RSU Vest (03/02/2025) 2,410 shares listed under Securities To Be Sold

Founder Shares (12/09/2013) 2,000 shares listed under Securities To Be Sold

RSU Vest (03/02/2024) 7,752 shares listed under Securities To Be Sold

RSU Vest (09/02/2023) 12,075 shares listed under Securities To Be Sold

Key Terms

Form 144, RSU Vest, Founder Shares, Delaware Trust

4 terms

Form 144 regulatory

"144: Securities Sold During The Past 3 Months"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

RSU Vest financial

"Common | 03/02/2025 | RSU Vest | Issuer"

Founder Shares financial

"Common | 12/09/2013 | Founder Shares | Issuer"

Founder shares are the ownership stakes given to the people who start a company, often with extra voting power or protections compared with ordinary shares. For investors, they matter because founders’ control and incentives influence decisions about strategy, hiring, and whether the company sells or stays independent — like a family that keeps majority voting rights in a household decision. High founder ownership can mean stable leadership but also a risk that outside shareholders have less influence.

Delaware Trust legal

"The Claire Pickering 2020 Delaware Trust 825 INDUSTRIAL ROAD"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the PCVX Form 144 disclose about recent affiliate sales?

The Form 144 reports three recent sales on 06/18/2026. Grant Pickering sold 22,461 shares for $1,179,204.75, and two trusts each sold 1,000 shares for $52,500.00.

Which types of securities are listed for proposed resale in the PCVX filing?

The filing lists Common stock tied to grant types including RSU Vest (various vest dates) and Founder Shares, with explicit per-grant quantities such as 2,410, 2,000, 7,752, and 12,075 shares.

Who is the broker or agent identified in the PCVX Form 144?

The filing shows UBS Financial Services, Inc. at 11 Madison Ave, New York, as the broker/agent referenced in the securities information section of the notice.

Does the Form 144 show proceeds or prices for the disclosed sales?

Yes. The excerpt shows sale proceeds: $1,179,204.75 for 22,461 shares sold by Grant Pickering, and $52,500.00 for each of two separate 1,000-share sales by the named trusts.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/26/2026 - 04:05 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001258693
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Vaxcyte, Inc.
SEC File Number	001-39323
Address of Issuer	825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CALIFORNIA 94070
Phone	650-837-0111
Name of Person for Whose Account the Securities are To Be Sold	PICKERING GRANT
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. 11 Madison Ave 4th Floor New York NY 10010	24237	1303223.49	144397682	06/26/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/02/2025	RSU Vest	Issuer			2410	03/02/2025	NA
Common	12/09/2013	Founder Shares	Issuer			2000	12/09/2013	NA
Common	03/02/2024	RSU Vest	Issuer			7752	03/02/2024	N/A
Common	09/02/2023	RSU Vest	Issuer			12075	09/02/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Grant Pickering 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070	Common	06/18/2026	22461	1179204.75
The Claire Pickering 2020 Delaware Trust 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070	Common	06/18/2026	1000	52500.00
The Benjamin Pickering 2020 Delaware Trust 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070	Common	06/18/2026	1000	52500.00

144: Remarks and Signature

Remarks	22,237 shares represented in this filing are being sold under Grant Pickering, 1,000 shares are being sold under the Claire Pickering 2020 Delaware Trust and 1,000 shares are being sold under the Benjamin Pickering 2020Delaware Trust.
Date of Notice	06/26/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/03/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc, as attorney-in-fact for Grant Pickering
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)